Triangle Biotechnology was founded with the mission to accelerate research by providing revolutionary sample preparation solutions. The company focuses on delivering innovative, high-quality, and high-throughput sonication systems for biological sample preparation. Their product offerings include fast, simple, and affordable systems for DNA shearing for next-generation sequencing (NGS), chromatin shearing for chromatin immunoprecipitation (ChIP), and efficient cell lysis methods. Triangle Biotechnology aims to simplify and expedite the sample prep process, making it less time-consuming and more cost-effective for researchers.
Notable affiliated individuals and investors have not been specified, but the company's impact is evident through its key achievements in developing cutting-edge sample prep technologies. Triangle Biotechnology has made significant strides in the life sciences sector by addressing the challenges associated with sample preparation, thereby enhancing research efficiency and productivity. Their innovative solutions have positioned them as a valuable player in the market, contributing to advancements in genomic research and molecular biology.